News | 24 September 2022
Unichem Laboratories sale its stake in Optimus Drugs
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Lenalidomide is used to treat various types of cancers.
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Subscribe To Our Newsletter & Stay Updated
